Globus Medical (GMED) EBITDA Margin Growth (1y) (2012 - 2026)

Globus Medical (GMED) EBITDA Margin Growth (1y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin Growth (1y) (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -430.00
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 128.00
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -361.00
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 141.00
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 102.00
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 58.00
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 851.00
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -313.00
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 535.00
10 Globus Medical 10.71 Bn 10.08 Bn 525.79 Mn 283.00

Historic Data

Download Data
DateValue
Mar 31, 2026 283.00
Dec 31, 2025 1,350.00
Sep 30, 2025 649.00
Jun 30, 2025 2,396.00
Mar 31, 2025 1,472.00
Dec 31, 2024 22.00
Sep 30, 2024 872.00
Jun 30, 2024 -1,500.00
Mar 31, 2024 -2,095.00
Dec 31, 2023 -1,718.00
Sep 30, 2023 -1,562.00
Jun 30, 2023 232.00
Mar 31, 2023 763.00
Dec 31, 2022 1,645.00
Sep 30, 2022 -394.00
Jun 30, 2022 94.00
Mar 31, 2022 -539.00
Dec 31, 2021 -1,888.00
Sep 30, 2021 -98.00
Jun 30, 2021 2,556.00